Green Dialysis: Hemodialysis With Reduced Dialysate Flow
Blood and dialysate sampling
Treatment Study
Summary
Study start date: July 18, 2023
Actual date on which the first participant was enrolled.This study explores a new approach to hemodialysis, which is a treatment used to clean the blood in patients with kidney failure. The current methods use a lot of water, which can be concerning from an environmental standpoint. This research aims to determine if using less water during hemodialysis, by reducing the flow of dialysate, can still effectively remove waste toxins from the blood. Specifically, it looks at comparing the effectiveness of different types of membranes used in the process to see if smaller, more open fibers in the dialyzer might be more efficient. Participants in this study will undergo hemodialysis using either a standard high-flux dialyzer or a medium cut-off membrane with varying dialysate flows. The process will measure how well these methods remove certain toxins that build up in the blood due to kidney failure. While the study does not mention specific risks or benefits, the goal is to find a method that minimizes water use without compromising the treatment's effectiveness. By focusing on different dialyzer types and flow rates, the study aims to improve the sustainability of hemodialysis treatments.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.10 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalGroup III
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location